Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Times Interest Earned (2016 - 2025)

Cytokinetics (CYTK) has disclosed Times Interest Earned for 12 consecutive years, with -$11.65 as the latest value for Q4 2025.

  • On a quarterly basis, Times Interest Earned changed N/A to -$11.65 in Q4 2025 year-over-year; TTM through Dec 2025 was -$15.69, a N/A change, with the full-year FY2025 number at -$13.43, up 5.56% from a year prior.
  • Times Interest Earned was -$11.65 for Q4 2025 at Cytokinetics, up from -$15.77 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$3.87 in Q2 2022 to a low of -$28.35 in Q1 2022.
  • A 5-year average of -$14.82 and a median of -$16.28 in 2021 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: tumbled 1375.55% in 2021, then surged 71.21% in 2022.
  • Cytokinetics' Times Interest Earned stood at -$5.15 in 2021, then tumbled by 249.83% to -$18.0 in 2022, then rose by 1.19% to -$17.79 in 2023, then grew by 11.33% to -$15.77 in 2024, then grew by 26.15% to -$11.65 in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Times Interest Earned are -$11.65 (Q4 2025), -$15.77 (Q3 2024), and -$10.22 (Q2 2024).